LOSS OF EPIDERMAL GROWTH-FACTOR REQUIREMENT AND MALIGNANT TRANSFORMATION

被引:124
|
作者
CHERINGTON, PV
SMITH, BL
PARDEE, AB
机构
[1] SIDNEY FARBER CANC INST, TUMOR BIOL LAB, BOSTON, MA 02115 USA
[2] HARVARD UNIV, SCH MED, DEPT PHARMACOL, BOSTON, MA 02115 USA
[3] HARVARD UNIV, SCH MED, DEPT MICROBIOL & MOLEC GENET, BOSTON, MA 02115 USA
关键词
D O I
10.1073/pnas.76.8.3937
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Serum provides growth factors that regulate and limit the growth of normal cells in tissue culture. Animal cells that are malignantly transformed usually exhibit diminished serum requirements for growth in culture. A defined, serum-free medium was used to determine which of these growth factors becomes dispensable for the growth of transformed Syrian and Chinese hamster fibroblast cells. The medium''s 4 growth factors (epidermal growth factor (EGF), insulin, fibroblast growth factor and transferrin) were added or omitted as desired. A decreased requirement for EGF was most closely related to tumorigenicity of chemically (ethyl methanesulfonate) transformed cells in nude mice. All lines examined retained their requirement for transferrin, which is needed throughout the growth cycle, in contrast to the other factors, which are needed primarily in G1 phase. Lines that had lost their EGF requirement but had retained their insulin requirement were arrested in G1 by insulin deficiency, indicating that their growth control system remained. Mutagenesis with ethyl methanesulfonate can also create requirements of the transformed cells for unknown factors in serum. An initial step that reduces the serum requirement in culture and in tumorigenesis is apparently relaxation of the growth-regulatory function of EGF.
引用
收藏
页码:3937 / 3941
页数:5
相关论文
共 50 条
  • [1] DECREASED EXPRESSION OF EPIDERMAL GROWTH-FACTOR AND ITS RECEPTOR IN THE MALIGNANT TRANSFORMATION OF TROPHOBLASTS
    LADINESLLAVE, CA
    MARUO, T
    MANALO, AM
    MOCHIZUKI, M
    CANCER, 1993, 71 (12) : 4118 - 4123
  • [2] REQUIREMENT FOR PHOSPHATIDYLINOSITOL TRANSFER PROTEIN IN EPIDERMAL GROWTH-FACTOR SIGNALING
    KAUFFMANNZEH, A
    THOMAS, GMH
    BALL, A
    PROSSER, S
    CUNNINGHAM, E
    COCKCROFT, S
    HSUAN, JJ
    SCIENCE, 1995, 268 (5214) : 1188 - 1190
  • [3] CHOLERA-TOXIN POTENTIATES DOWN REGULATION OF EPIDERMAL GROWTH-FACTOR RECEPTORS BY PLATELET-DERIVED GROWTH-FACTOR AND ABROGATES THE REQUIREMENT FOR EPIDERMAL GROWTH-FACTOR IN MITOGENESIS
    OKEEFE, EJ
    WHARTON, W
    LEOF, E
    PLEDGER, WJ
    CLINICAL RESEARCH, 1982, 30 (02): : A488 - A488
  • [4] EPIDERMAL GROWTH FACTOR-RELATED PEPTIDES AND THE EPIDERMAL GROWTH-FACTOR RECEPTOR IN NORMAL AND MALIGNANT PROSTATE
    SHERWOOD, ER
    LEE, C
    WORLD JOURNAL OF UROLOGY, 1995, 13 (05) : 290 - 296
  • [5] LOSS OF EPIDERMAL GROWTH-FACTOR RECEPTOR GENE AMPLIFICATION AS MALIGNANT HUMAN GLIOMAS ESTABLISH IN CULTURE
    HUMPHREY, PA
    WONG, AJ
    VOGELSTEIN, B
    FRIEDMAN, HS
    BIGNER, DD
    BIGNER, SH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 78 - 78
  • [6] EPIDERMAL GROWTH-FACTOR REQUIREMENT FOR DEVELOPMENT OF CULTURED MAMMARY-GLAND
    TONELLI, QJ
    SOROF, S
    NATURE, 1980, 285 (5762) : 250 - 252
  • [7] PLATELET-DERIVED GROWTH-FACTOR AND MALIGNANT TRANSFORMATION
    ANTONIADES, HN
    BIOCHEMICAL PHARMACOLOGY, 1984, 33 (18) : 2823 - 2828
  • [8] THE EPIDERMAL GROWTH-FACTOR
    BOONSTRA, J
    RIJKEN, P
    HUMBEL, B
    CREMERS, F
    VERKLEIJ, A
    HENEGOUWEN, PVE
    CELL BIOLOGY INTERNATIONAL, 1995, 19 (05) : 413 - 430
  • [9] EPIDERMAL GROWTH-FACTOR
    COHEN, S
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1972, 59 (01) : 13 - +
  • [10] EPIDERMAL GROWTH-FACTOR
    CARPENTER, G
    COHEN, S
    ANNUAL REVIEW OF BIOCHEMISTRY, 1979, 48 : 193 - 216